COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,999 Articles (22,627 medRxiv, 8,372 bioRxiv)

Most recent first Previous |  Page 1827: Articles 18261-18270  | Next

The effectiveness of the first dose of BNT162 b 2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real-world evidence
Chodcik, G., Tene, L., Patalon, T., Gazit, S., Ben-Tov, A., Cohen, D., Muhsen, K.
10.1101/2021.01.27.21250612 — Posted: 2021-01-29 Discussion: Onsite
Sequencing Data of North American SARS-CoV-2 Isolates Shows Widespread Complex Variants
Ford, C. T., Scott, R., Jacob Machado, D., Janies, D.
10.1101/2021.01.27.21250648 — Posted: 2021-01-29
Passing the Test: A model-based analysis of safe school-reopening strategies
Bilinski, A. M., Salomon, J. A., Giardina, J., Ciaranello, A., Fitzpatrick, M.
10.1101/2021.01.27.21250388 — Posted: 2021-01-29
Self-Reported Mask Wearing Greatly Exceeds Directly Observed Use: Urgent Need for Policy Intervention in Kenya
Jakubowski, A., Egger, D., Nekesa, C., Lowe, L., Walker, M., Miguel, E.
10.1101/2021.01.27.21250487 — Posted: 2021-01-29
The prevalence of olfactory dysfunction and its associated factors in patients with COVID-19 infection
Hasan, M. M., Tamanna, N. A., Jamal, M. N., Uddin, M. J.
10.1101/2021.01.27.21250153 — Posted: 2021-01-29
Induction of labour during the COVID-19 pandemic: a national survey of impact on practice in the UK
Harkness, M., Yuill, C., Cheyne, H., Stock, S., McCourt, C.
10.1101/2021.01.27.21250521 — Posted: 2021-01-29
The Experience of Two Independent Schools with In-Person Learning During the COVID-19 Pandemic
Gillespie, D. L., Meyers, L. A., Lachmann, M., Redd, S. C., Zenilman, J. M.
10.1101/2021.01.26.21250065 — Posted: 2021-01-29
COVID-19 mortality: positive correlation with cloudiness and sunlight but no correlation with latitude in Europe
Omer, S., Iftime, A., Burcea, V. A.
10.1101/2021.01.27.21250658 — Posted: 2021-01-29 Discussion: Onsite
The effect of SARS-CoV-2 variant B.1.1.7 on symptomatology, re-infection and transmissibility
Graham, M. S., Sudre, C. H., May, A., Antonelli, M., Murray, B., Varsavsky, T., Klaser, K., Canas, L. D. S., Molteni, E., Modat, M., Drew, D. A., Nguyen, L. A., Polidori, L., Selvachandran, S., Hu, C., Capdevila Pujol, J., The COVID-19 Genomics UK (COG-UK) consortium, , Hammers, A., Chan, A. T., Wolf, J., Spector, T., Steves, C., Ourselin, S.
10.1101/2021.01.28.21250680 — Posted: 2021-01-29
Evaluation of COVID-19 vaccination strategies with a delayed second dose
Moghadas, S. M., Vilches, T. N., Zhang, K., Nourbakhsh, S., Sah, P., Fitzpatrick, M. C., Galvani, A. P.
10.1101/2021.01.27.21250619 — Posted: 2021-01-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).